Literature DB >> 15806425

Cardiac myocyte differentiation: the Nkx2.5 and Cripto target genes in P19 clone 6 cells.

Hailing Liu1, Thomas M Harris, Hyung H Kim, Geoffrey Childs.   

Abstract

Genetic evidence has implicated several genes as being critical for the development of cardiomyocytes. Whereas a few of the targets of these genes and the pathways they constitute are known the majority of targets and the interrelationships of the pathways involved still remains largely unknown. The power of high-throughput analytical techniques like microarrays and real-time RT-PCR combined with the ability to selectively silence specific mRNA in model tissue culture systems can begin to fill in these gaps and increase our understanding of the molecular mechanisms of cell commitment and terminal differentiation. We have used microarray analysis and siRNA directed against the cardiac-specific transcription factor Nkx2.5 and one of its targets Cripto in P19 clone 6 (P19Cl6) cells to identify potential targets for these genes. We demonstrate Nkx2.5 affects genes that have been shown to be controlled by the canonical Wnt or TGFbeta/BMP signaling pathways. We also show that Cripto can regulate the critical stem cell gene Nanog and two Oct 4-regulated genes: Dppa2 and 4. Cripto also affects the formation of nitric oxide, a small signaling molecule that has been reported to be important for growth and development of cardiac and smooth muscle. It affects the nitric oxide system by regulating genes that control the levels of nitric oxide synthase mRNA concentration as well as the activation and bioavailability of the protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15806425     DOI: 10.1007/s10142-005-0140-7

Source DB:  PubMed          Journal:  Funct Integr Genomics        ISSN: 1438-793X            Impact factor:   3.410


  69 in total

1.  TGFbeta Type III and TGFbeta Type II receptors have distinct activities during epithelial-mesenchymal cell transformation in the embryonic heart.

Authors:  A S Boyer; R B Runyan
Journal:  Dev Dyn       Date:  2001-08       Impact factor: 3.780

Review 2.  Cripto in tumors and embryo development.

Authors:  M G Persico; G L Liguori; S Parisi; D D'Andrea; D S Salomon; G Minchiotti
Journal:  Biochim Biophys Acta       Date:  2001-12-28

3.  Activin-binding protein from rat ovary is follistatin.

Authors:  T Nakamura; K Takio; Y Eto; H Shibai; K Titani; H Sugino
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

4.  P311 induces a TGF-beta1-independent, nonfibrogenic myofibroblast phenotype.

Authors:  Desi Pan; Xiaoning Zhe; Sandhya Jakkaraju; Gregory A Taylor; Lucia Schuger
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

5.  Microarray analysis of global changes in gene expression during cardiac myocyte differentiation.

Authors:  Chang-Fu Peng; Yi Wei; Jeffrey M Levsky; Thomas V McDonald; Geoffrey Childs; Richard N Kitsis
Journal:  Physiol Genomics       Date:  2002-04-16       Impact factor: 3.107

6.  Early stage-specific inhibitions of cardiomyocyte differentiation and expression of Csx/Nkx-2.5 and GATA-4 by phosphatidylinositol 3-kinase inhibitor LY294002.

Authors:  Atsuhiko T Naito; Aki Tominaga; Masahito Oyamada; Yumiko Oyamada; Isao Shiraishi; Koshiro Monzen; Issei Komuro; Tetsuro Takamatsu
Journal:  Exp Cell Res       Date:  2003-11-15       Impact factor: 3.905

7.  Regulation of avian cardiac myogenesis by activin/TGFbeta and bone morphogenetic proteins.

Authors:  A N Ladd; T A Yatskievych; P B Antin
Journal:  Dev Biol       Date:  1998-12-15       Impact factor: 3.582

8.  Differentiation of beating cardiac muscle cells from a derivative of P19 embryonal carcinoma cells.

Authors:  A Habara-Ohkubo
Journal:  Cell Struct Funct       Date:  1996-04       Impact factor: 2.212

9.  Extracellular fibrillar structure of latent TGF beta binding protein-1: role in TGF beta-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart.

Authors:  Y Nakajima; K Miyazono; M Kato; M Takase; T Yamagishi; H Nakamura
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

10.  The gene tinman is required for specification of the heart and visceral muscles in Drosophila.

Authors:  R Bodmer
Journal:  Development       Date:  1993-07       Impact factor: 6.868

View more
  5 in total

1.  Stat3 directly controls the expression of Tbx5, Nkx2.5, and GATA4 and is essential for cardiomyocyte differentiation of P19CL6 cells.

Authors:  Marylynn Snyder; Xin-Yun Huang; J Jillian Zhang
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

Review 2.  Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.

Authors:  Maria C Rangel; Hideaki Karasawa; Nadia P Castro; Tadahiro Nagaoka; David S Salomon; Caterina Bianco
Journal:  Am J Pathol       Date:  2012-04-26       Impact factor: 4.307

3.  Nkx2-5 Regulates Tdgf1 (Cripto) Early During Cardiac Development.

Authors:  Ann N Behrens; Yi Ren; Anwarul Ferdous; Daniel J Garry; Cindy M Martin
Journal:  J Clin Exp Cardiolog       Date:  2012

4.  Silencing of TBX20 gene expression in rat myocardial and human embryonic kidney cells leads to cell cycle arrest in G2 phase.

Authors:  Peiyan Liu; Yueling Sun; Guangbin Qiu; Hongkun Jiang; Guangrong Qiu
Journal:  Mol Med Rep       Date:  2016-08-19       Impact factor: 2.952

5.  NKX2-5 regulates human cardiomyogenesis via a HEY2 dependent transcriptional network.

Authors:  David J Anderson; David I Kaplan; Katrina M Bell; Katerina Koutsis; John M Haynes; Richard J Mills; Dean G Phelan; Elizabeth L Qian; Ana Rita Leitoguinho; Deevina Arasaratnam; Tanya Labonne; Elizabeth S Ng; Richard P Davis; Simona Casini; Robert Passier; James E Hudson; Enzo R Porrello; Mauro W Costa; Arash Rafii; Clare L Curl; Lea M Delbridge; Richard P Harvey; Alicia Oshlack; Michael M Cheung; Christine L Mummery; Stephen Petrou; Andrew G Elefanty; Edouard G Stanley; David A Elliott
Journal:  Nat Commun       Date:  2018-04-10       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.